Inovio Pharmaceuticals Cash Flow Statement (2010-2025) | INO

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-53.97M-82.14M-60.17M-106.95M-76.91M-108.50M-37.78M-54.46M-40.65M-35.53M-33.93M-25.00M-30.16M-31.89M-26.24M-19.52M-24.24M-22.47M-20.66M-17.03M
Depreciation and Depletion (Quarter)
0.66M0.70M0.73M0.95M0.93M0.94M0.91M0.88M0.71M0.70M0.64M0.57M0.42M0.49M0.42M0.42M0.37M0.36M0.35M0.32M
Share-based Compensation (Quarter)
9.60M0.31M5.30M5.47M7.71M0.41M3.00M3.27M3.81M0.15M1.90M2.27M2.53M1.50M0.04M1.32M1.40M0.74M0.76M
Gains from Equity Investments (Quarter)
Gains from Investment Securities (Quarter)
3.92M-3.92M1.03M-1.35M-0.94M0.19M-2.43M2.09M-3.52M-0.95M-2.79M-482.001.88M22.52M
Asset Writedowns and Impairment (Quarter)
2.00M
Cash from Operations (Quarter)
-52.87M-78.46M-46.49M-37.89M-61.88M-50.53M-67.47M-36.34M-36.66M-32.31M-29.11M-26.28M-28.76M-28.21M-27.44M-19.66M-26.87M-20.81M-21.57M-19.37M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
10.51M
Amortizatization of Intangibles (Quarter)
0.13M0.13M1.67M0.32M0.13M0.12M0.33M0.08M0.06M0.68M-0.01M0.35M0.67M0.37M-0.36M-0.06M0.05M
Depreciation & Amortization (CF) (Quarter)
0.66M0.70M0.73M0.95M0.93M0.94M0.91M0.88M0.71M0.70M0.64M0.57M0.42M0.49M0.42M0.42M0.37M0.36M0.35M0.32M
Change in Working Capital
Change in Receivables (Quarter)
-8.80M3.59M-6.73M0.91M-0.54M3.88M-1.29M1.66M-6.70M0.08M-2.97M0.26M0.15M-0.78M0.09M-0.66M0.11M-0.47M0.14M
Change in Account Payables (Quarter)
0.13M1.01M-1.28M0.06M0.86M
Change in Accured Expenses (Quarter)
0.01M-0.05M-0.01M27.34M5.28M-40.74M-3.22M-6.69M4.65M-3.16M0.80M-1.98M0.86M-4.16M2.66M-0.35M-4.58M
Investing Activities
Capital Expenditures (Quarter)
0.21M0.21M-0.39M0.18M0.33M-0.26M0.74M-0.70M0.30M0.02M0.44M0.04M0.07M0.09M0.13M
Sales of Property, Plant and Equipment (Quarter)
6.07M0.15M0.06M
Change in Intangibles (Quarter)
Change in Acquisitions & Divestments (Quarter)
0.50M82.96M56.73M34.64M123.06M30.07M108.82M99.14M93.66M80.24M62.01M49.02M55.17M30.03M38.86M6.95M0.01M10.26M8.94M-14.20M
Cash from Investing Activities (Quarter)
-275.12M50.31M55.96M-6.49M21.33M-10.30M44.56M54.00M19.00M53.91M-5.49M19.94M45.38M9.97M14.08M34.64M-0.05M5.28M8.87M-0.06M
Financing Activities
Other financing activities (Quarter)
-4.61M-0.42M-0.03M-0.01M-0.17M-0.24M-0.01M-0.07M-0.03M-0.00M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)
16.41M
Short-Term Debt repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
162.11M47.34M29.36M-29.18M0.09M2.92M-2.92M5.23M-5.16M22.88M13.08M1.10M-1.10M34.91M
Dividend Payments
Dividends Paid - Common (Quarter)
Misc.
Cash from Financing Activities (Quarter)
160.90M3.44M-0.44M47.59M28.42M42.94M3.81M6.67M-0.42M2.88M0.70M1.84M-11.36M33.03M0.66M29.15M1.03M-0.03M24.92M27.13M
Exchange Rate Effect (Quarter)
-0.01M0.00M-0.01M-0.01M-0.01M-0.01M-0.02M0.01M-0.00M-376.00-0.00M483.000.03M
Change in Cash (Quarter)
-167.09M-24.71M9.02M3.20M-12.13M-17.91M-19.11M24.34M-18.09M24.47M-33.91M-4.49M5.29M14.79M-12.70M44.13M-25.90M-15.56M12.22M7.71M
Free Cash Flow (Quarter)
-53.08M-78.67M-46.10M-38.07M-62.21M-50.26M-68.20M-35.64M-36.96M-32.34M-29.11M-26.28M-29.20M-28.25M-27.44M-19.66M-26.87M-20.88M-21.67M-19.50M
Net Cash Flow (Quarter)
-167.08M-24.71M9.03M3.21M-12.13M-17.89M-19.10M24.33M-18.09M24.47M-33.91M-4.49M5.26M14.79M-12.70M44.13M-25.90M-15.56M12.22M7.71M